betaxolol has been researched along with n-methylaspartate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, JH; Chidlow, G; DeSantis, L; Nash, MS; Osborne, NN; Ugarte, M; Wood, JP | 1 |
Melena, J; Osborne, NN; Stanton, D | 1 |
Chidlow, G; Cupido, A; Melena, J; Osborne, NN; Wood, JP | 1 |
Baldridge, WH; Baptiste, DC; Chauhan, BC; Hartwick, AT; Jollimore, CA; Kelly, ME; Tremblay, F | 1 |
Kalloniatis, M; Rait, JL; Sun, D | 1 |
Fletcher, EL | 1 |
Kalloniatis, M; Sun, D | 1 |
7 other study(ies) available for betaxolol and n-methylaspartate
Article | Year |
---|---|
Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium Channel Blockers; Choline O-Acetyltransferase; Electroretinography; Ganglia, Sensory; N-Methylaspartate; Neuroprotective Agents; Rabbits; Rats; Rats, Wistar; Reperfusion Injury; Retina; Retinal Diseases | 1999 |
Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Betaxolol; Calcium; Calcium Channels; Glaucoma; N-Methylaspartate; Radioligand Assay; Rats; Rats, Wistar; Retina | 2001 |
Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium; Calcium Channel Blockers; Choline O-Acetyltransferase; Electroretinography; Excitatory Amino Acid Agonists; Flunarizine; Intraocular Pressure; N-Methylaspartate; Neuroprotective Agents; Nifedipine; Parvalbumins; Rabbits; Rats; Rats, Wistar; Reperfusion Injury; Retina; RNA, Messenger; Sodium; Thy-1 Antigens; Vasodilator Agents | 2002 |
Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Brimonidine Tartrate; Calcium; Cell Culture Techniques; Cell Survival; Dose-Response Relationship, Drug; Fura-2; Glutamic Acid; Metoprolol; N-Methylaspartate; Neuroglia; Neuroprotective Agents; Quinoxalines; Rats; Rats, Long-Evans; Retina; Retinal Ganglion Cells; Timolol | 2002 |
Inner retinal neurons display differential responses to N-methyl-D-aspartate receptor activation.
Topics: Adrenergic beta-Antagonists; Agmatine; Amacrine Cells; Animals; Betaxolol; Dose-Response Relationship, Drug; Drug Synergism; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Immunohistochemistry; N-Methylaspartate; Neurons; Rabbits; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Ganglion Cells; Synaptic Transmission | 2003 |
Understanding neurochemical changes during retinal diseases.
Topics: Animals; Betaxolol; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; N-Methylaspartate; Neurons; Retina; Retinal Diseases | 2004 |
Quantification of amino acid neurochemistry secondary to NMDA or betaxolol application.
Topics: Adrenergic beta-Antagonists; Agmatine; Amacrine Cells; Animals; Betaxolol; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Immunohistochemistry; N-Methylaspartate; Neurons; Rabbits; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Ganglion Cells | 2004 |